AZN Share PerformanceMore
|52 week high||5,520.0 22/06/17|
|52 week low||4,260.0 27/07/17|
|52 week change||1.0 (0.02%)|
|4 week volume||50,212,261 19/02/18|
Latest News« previous» nextMore
14/03/2018 - 14:00 StockMarketWire
Societe Generale today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 7800...
12/03/2018 - 16:52 StockMarketWire
The FTSE 100 fell into the red on the back of the stronger pound following reports the UK is nearing a transition deal with...
12/03/2018 - 11:55 StockMarketWire
The FTSE 100 was up only 10.5 points at 7,235 as weakness in housebuilders and miners threatened to offset a strong perfor...
12/03/2018 - 07:54 StockMarketWire
AstraZeneca on Monday said it expects to deliver final analysis of its phase III MYSTIC trial of Imfinzi, a lung cancer trea...
12/03/2018 - 07:00 RNS
RNS Number: 3386H AstraZeneca PLC 12 March 2018 12 March 2018 07:00 GMT ASTRAZENECA PROVIDES UPDATE ON MYSTIC TRIAL TIMELINE AstraZeneca and MedImmune, its global biologics research and development arm, today announced an updated timeline for the final analysis of the Phase III MYSTIC trial of Imfinzi (durvalumab) as monother...
07/03/2018 - 07:00 RNS
RNS Number: 9071G AstraZeneca PLC 07 March 2018 7 March 2018 07:00 GMT FILING OF ANNUAL REPORT ON FORM 20-F WITH THE US SECURITIES AND EXCHANGE COMMISSION AstraZeneca PLC (the Company) announced today that, on 6 March 2018, it filed its 2017 Annual Report on Form 20-F with the US Securities and Exchange Commission (...
06/03/2018 - 11:00 RNS
RNS Number: 8323G AstraZeneca PLC 06 March 2018 6 March 2018 11.00 GMT ANNUAL FINANCIAL REPORT AstraZeneca PLC (the Company) announced today the publication of its Annual Report and Form 20-F Information 2017 (Annual Report). A copy of the Annual Report will be submitted to the National Storage Mechanism and will shortly be available ...
01/03/2018 - 15:00 RNS
RNS Number: 4345G AstraZeneca PLC 01 March 2018 1 March 2018 15:00 GMT Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 28 February 2018 the issued share capital of AstraZeneca PLC with voting rights is 1,266,448,828 ord...
Latest discussion posts More
“Maybe they remember back to when Pfizer were willing to offer #55 in 2014, they may be thinking they'll be back or the promise to " raise revenues by more than three quarters ...”▼
“Societe Generale today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 7800p. Story provided by StockMarketWire.com Broker ...”▼
“AstraZeneca on Monday said it expects to deliver final analysis of its phase III MYSTIC trial of Imfinzi in the second half of 2018 rather than the first half of the year as ...”▼
Codes & Symbols
|Symbols||AZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN|